Clinical Impact of Acthar in the Psoriatic Arthritis Patient (CLIPS)
Status:
Completed
Trial end date:
2021-08-25
Target enrollment:
Participant gender:
Summary
Demonstrate the clinical value of Acthar TM in patients with active Psoriatic Arthritis who
lack adequate response to DMARDS, and the quantification of response by clinical, serologic
and structural parameters.